P1295: ADVANTAGE OF FIRST-LINE TDM-DRIVEN USE OF INFLIXIMAB FOR TREATING ACUTE INTESTINAL AND LIVER GVHD IN CHILDREN: A PROSPECTIVE, SINGLE-CENTER STUDY.

• Natalia Maximova,
• Daniela Nistico’,
• Annalisa Marcuzzi,
• Erika Rimondi,
• Antimo Tessitore,
• Guglielmo Riccio,
• Egidio Barbi,
• Antonello DI Paolo

Affiliations

Natalia Maximova

1 Institute for Maternal and Child Health – IRCCS Burlo Garofolo, Trieste, Italy

Daniela Nistico’

2 University of Trieste, Trieste, Italy

Annalisa Marcuzzi

3 University of Ferrara, Ferrara, Italy

Erika Rimondi

3 University of Ferrara, Ferrara, Italy

Antimo Tessitore

2 University of Trieste, Trieste, Italy

Guglielmo Riccio

2 University of Trieste, Trieste, Italy

Egidio Barbi

1 Institute for Maternal and Child Health – IRCCS Burlo Garofolo, Trieste, Italy

Antonello DI Paolo

4 University of Pisa, Pisa, Italy